MYC, a proto-oncogene overactivated in malignancies, drives glycolytic flux amplification while suppressing ALDOB transcription—a mechanism implicated in cancer metabolic rewiring toward aerobic glycolysis (Warburg effect)18. This evidence concerns the gene MYC and cancer.